Trial Profile
Phase I study of Tau Morphomers for Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 May 2018
Price :
$35
*
At a glance
- Drugs Tau Morphomers (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 09 May 2018 New trial record
- 02 May 2018 According to an AC Immune media release, Tau Morphomers have entered into IND/CTA enabling studies and this phase I study will commence by the end of 2018.